Research on the Carcinogenicity of Nanoparticles and other D

 
Post new topic   Reply to topic    Institute of Nanotechnology Forum Index -> Nanobiomed
View previous topic :: View next topic  
Author Message
nanoorg
Site Admin


Joined: 16 Mar 2004
Posts: 1392

PostPosted: Tue Aug 11, 2009 11:49 am    Post subject: Research on the Carcinogenicity of Nanoparticles and other D Reply with quote

The primary aims of the study by the Federal Institute for Occupational Safety and Health in Germany were to analyse differences between the carcinogenicity of granular dusts in the rat lung after intratracheal instillation, to find out the optimal dose metric for their carcinogenic potency and to interprete their potential relevance for human health.

Nineteen dusts were choosen for the experiment, which differed at least in one of the following properties of their particles: chemical composition, density, specific surface area (according to the so called BET method) and mean particle size. Quartz and amorphous silica were included in the study as dusts with known specific toxicity; little was known about the toxicity of some dusts. Also, coated hydrophobic TiO2 had been selected that had not been tested before and showed strong acute toxicity.

Sixteen of the 19 dusts formed a group for which no specific toxicity was detected which seemed to be essential for their carcinogenicity in this experiment. Accordingly, these dusts were defined as respirable granular bio-durable particles without known significant specific toxicity (GBP, the three letters of the abbreviation are to cover all nine words) in the frame of this carcinogenicity experiment.

Regarding the size of the primary particles, 4 of the 16 GBP were clearly ultrafine dusts (GBP-UF, mean diameters 0.01 - 0.03 m); they are also called nanoparticles. The other 12 GBP were classified as fine dusts (GBP-F, mean diameters 0.09 - 4.0 m). The results suggested subdividing this large group into two groups with different diameters: 4 small-fine dusts (GBP-F-sm, mean diameters 0.09 - 0.2 m) and 8 large-fine dusts (GBP-F-la, mean diameters 1.8 - 4 m).

All 16 GBP produced lung tumours, many more than expected. The microscopically diagnosed lung tumour incidences were used for non-linear regression analysis. The GBP volume in connection with particle size turned out to be the most adequate dose metric for the carcinogenicity of GBP. The 4 tested GBP-UF were about 2 times more effective than the "small" GBP-F-sm and 5- to 6 times more effective than the "large" GBP-F-la.

An effect threshold of carcinogenicity of GBP in the range of the General Threshold Limit Value for Dust is extremely unlikely for rats, if all inhalation and instillation studies are considered. The additional cancer risk after exposure of rats to GBP-F was calculated as 1 - 3 % for the exposure scenario of the General Threshold Limit Value for respirable dust of 3 mg/m, which is in force since 2001.

Many arguments speak against the hypothesis that the mechanism which causes the dust related lung tumours in rats does not exist in humans. Some epidemiological data indicate that a similar carcinogenic potency may exist for humans and rats related to the long-term (i.e. same proportion of life expectancy) exposure concentration. However, the limit for a statistically "unequivocally" increased risk is very high (absolute excess risk greater than 5 - 10 %) for the most studies both with humans and with rats. Overall, the state of knowledge meets the EU criteria for a classification of GBP into category 2 of carcinogenic substances.

A copy of the complete report "Research on the carcinogenicity of nanoparticles and other dusts" can be downloaded from the BAuA website (German language only).

M. Roller:
Research on the carcinogenicity of nanoparticles and other dusts
1. Edition. Dortmund: Bundesanstalt fr Arbeitsschutz und Arbeitsmedizin 2008.
ISBN: 978-3-88261-069-7, 309 pages, project number: F 2083, paper, pdf file

Bundesanstalt fr Arbeitsschutz und Arbeitsmedizin (BAuA)
Informationszentrum
Postbox 17 02 02
44061 Dortmund
Phone 0231 9071-2071
Fax 0231 9071-2070
email: info-zentrum@baua.bund.de

Source: Bundesanstalt fr Arbeitsschutz und Arbeitsmedizin
Back to top
View user's profile Send private message
Display posts from previous:   
Post new topic   Reply to topic    Institute of Nanotechnology Forum Index -> Nanobiomed All times are GMT
Page 1 of 1
 

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum


Powered by phpBB © 2001, 2002 phpBB Group